angiotensin ii has been researched along with Degenerative Diseases, Central Nervous System in 7 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (85.71) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Diaz-Ruiz, C; Dominguez-Meijide, A; Garrido-Gil, P; Guerra, MJ; Labandeira-Garcia, JL; Villar-Cheda, B | 1 |
Lin, X; Lu, J; Shi, J; Tian, M; Wu, L; Zhang, Y | 1 |
Re, RN | 1 |
Beiroa, D; Diaz-Ruiz, C; Labandeira-Garcia, JL; Rodriguez-Pallares, J; Rodriguez-Perez, AI | 1 |
Borrajo, A; Diaz-Ruiz, C; Garrido-Gil, P; Labandeira-Garcia, JL; Rodriguez-Perez, AI | 1 |
Dikalov, S | 1 |
Saavedra, JM | 1 |
3 review(s) available for angiotensin ii and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
A possible mechanism for the progression of chronic renal disease and congestive heart failure.
Topics: Angiotensin II; Disease Progression; Heart Failure; Humans; Neurodegenerative Diseases; Renal Insufficiency, Chronic; Renin-Angiotensin System; Up-Regulation | 2015 |
Cross talk between mitochondria and NADPH oxidases.
Topics: Aging; Angiotensin II; Animals; Antioxidants; Atherosclerosis; Diabetes Mellitus; Humans; Hypertension; Mice; Mitochondria; NADPH Oxidases; Neurodegenerative Diseases; Nitric Oxide Synthase Type III; Organophosphorus Compounds; Oxidation-Reduction; Oxidative Stress; Piperidines; Rabbits; Rats; Reactive Oxygen Species; Signal Transduction; Superoxide Dismutase; Xanthine Oxidase | 2011 |
Angiotensin II AT(1) receptor blockers as treatments for inflammatory brain disorders.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Biomarkers; Brain; Brain Diseases; Brain Injuries; Brain Ischemia; Humans; Inflammation; Mood Disorders; Neurodegenerative Diseases; Neuroprotective Agents; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Risk Factors; Stress, Physiological; Stroke | 2012 |
4 other study(ies) available for angiotensin ii and Degenerative Diseases, Central Nervous System
Article | Year |
---|---|
Aging-Related Overactivity of the Angiotensin/AT1 Axis Decreases Sirtuin 3 Levels in the Substantia Nigra, Which Induces Vulnerability to Oxidative Stress and Neurodegeneration.
Topics: Age Factors; Angiotensin II; Animals; Male; Mice; Neurodegenerative Diseases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Sirtuin 3; Substantia Nigra | 2020 |
Angiotensin II triggers autophagy and apoptosis in PC12 cell line: An in vitro Alzheimer's disease model.
Topics: Alzheimer Disease; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Apoptosis; Autophagy; Imidazoles; Losartan; Models, Biological; Neurodegenerative Diseases; PC12 Cells; Pyridines; Rats; Receptor, Angiotensin, Type 1 | 2019 |
Reciprocal regulation between sirtuin-1 and angiotensin-II in the substantia nigra: implications for aging and neurodegeneration.
Topics: Aging; Angiotensin II; Animals; Brain; Cell Line; Dopaminergic Neurons; Gene Expression Regulation; Homozygote; Humans; Immunohistochemistry; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Microscopy, Fluorescence; NADPH Oxidases; Neurodegenerative Diseases; Neuroglia; Neurons; Oxidative Stress; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Resveratrol; Sirtuin 1; Stilbenes; Substantia Nigra | 2015 |
Crosstalk between insulin-like growth factor-1 and angiotensin-II in dopaminergic neurons and glial cells: role in neuroinflammation and aging.
Topics: 1-Methyl-4-phenylpyridinium; Age Factors; Aging; Angiotensin II; Animals; Apoptosis; Cells, Cultured; Dopaminergic Neurons; Fluorescent Antibody Technique; Humans; Immunohistochemistry; Inflammation; Injections, Intraventricular; Insulin-Like Growth Factor I; Microglia; Neurodegenerative Diseases; Oxidative Stress; Primary Cell Culture; Rats; Receptor, Angiotensin, Type 1; Receptor, IGF Type 1; Renin-Angiotensin System; Substantia Nigra | 2016 |